Morishita Jintan Co., Ltd. (4524.T)

JPY 2065.0

(0.05%)

Total Assets Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual total assets in 2023 was 17.18 Billion JPY , up 6.71% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly total assets in 2024 Q1 was 17.94 Billion JPY , up 4.42% from previous quarter.
  • Morishita Jintan Co., Ltd. reported annual total assets of 16.1 Billion JPY in 2022, up 11.22% from previous year.
  • Morishita Jintan Co., Ltd. reported annual total assets of 14.47 Billion JPY in 2021, up 0.23% from previous year.
  • Morishita Jintan Co., Ltd. reported quarterly total assets of 17.6 Billion JPY for 2023 Q2, up 4.81% from previous quarter.
  • Morishita Jintan Co., Ltd. reported quarterly total assets of 17.18 Billion JPY for 2023 Q4, up 0.03% from previous quarter.

Annual Total Assets Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Historical Annual Total Assets of Morishita Jintan Co., Ltd. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 17.18 Billion JPY 6.71%
2022 16.1 Billion JPY 11.22%
2021 14.47 Billion JPY 0.23%
2020 14.44 Billion JPY 0.41%
2019 14.38 Billion JPY 0.0%

Peer Total Assets Comparison of Morishita Jintan Co., Ltd.

Name Total Assets Total Assets Difference
Pharma Foods International Co., Ltd. 36.57 Billion JPY 53.017%
Takeda Pharmaceutical Company Limited 15108.79 Billion JPY 99.886%
Sumitomo Pharma Co., Ltd. 907.5 Billion JPY 98.107%
Shionogi & Co., Ltd. 1416.91 Billion JPY 98.787%
Wakamoto Pharmaceutical Co.,Ltd. 15.42 Billion JPY -11.426%
Nippon Shinyaku Co., Ltd. 263.4 Billion JPY 93.477%
Kaken Pharmaceutical Co., Ltd. 171.62 Billion JPY 89.988%
Eisai Co., Ltd. 1393.79 Billion JPY 98.767%
Hisamitsu Pharmaceutical Co., Inc. 328.77 Billion JPY 94.774%
Mochida Pharmaceutical Co., Ltd. 158.8 Billion JPY 89.179%
Fuso Pharmaceutical Industries,Ltd. 76.46 Billion JPY 77.527%
Nippon Chemiphar Co., Ltd. 49.54 Billion JPY 65.32%
Tsumura & Co. 428.25 Billion JPY 95.988%
Kissei Pharmaceutical Co., Ltd. 260.92 Billion JPY 93.415%
Torii Pharmaceutical Co., Ltd. 133.43 Billion JPY 87.122%
Towa Pharmaceutical Co., Ltd. 430.65 Billion JPY 96.01%
Fuji Pharma Co., Ltd. 85.33 Billion JPY 79.863%
Zeria Pharmaceutical Co., Ltd. 150.53 Billion JPY 88.585%
KYORIN Holdings, Inc. 177.67 Billion JPY 90.329%
Taiko Pharmaceutical Co.,Ltd. 15.04 Billion JPY -14.203%
Daito Pharmaceutical Co.,Ltd. 77.7 Billion JPY 77.888%
SymBio Pharmaceuticals Limited 15.35 Billion JPY -11.926%
MedRx Co., Ltd 2.05 Billion JPY -737.378%
Mizuho Medy Co.,Ltd. 18.94 Billion JPY 9.317%
Solasia Pharma K.K. 2.55 Billion JPY -573.843%
Modalis Therapeutics Corporation 2.02 Billion JPY -748.156%
ASKA Pharmaceutical Holdings Co.,Ltd. 93.31 Billion JPY 81.585%
Sawai Group Holdings Co., Ltd. 382.02 Billion JPY 95.502%
Cyfuse Biomedical K.K. 4.21 Billion JPY -307.682%
Toho Holdings Co., Ltd. 773.42 Billion JPY 97.778%
Koa Shoji Holdings Co.,Ltd. 32 Billion JPY 46.31%